LITS

#4412
Lite Strategy, Inc. - Common Stock
0.9 9 USD
+0.01%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
0.99
0.99
Intervallo Annuale
0.69
3.23
Variazione giornaliera
+1.02%
Variazione Mensile
+2.06%
Variazione di 6 mesi
-8.33%
Variazione Annuale
-66.78%
Chiusura Precedente
0.9 8
Open
0.9 9
Minimo
0.9 9
Massimo
0.9 9
Volume
3
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi Documents

2026

Current report, Q3 FY2026
Lite Strategy, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Lite Strategy, Inc. current report, Q3 FY2026
8-K
Current report, Q2 FY2026
Lite Strategy, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q3 FY2026
Lite Strategy, Inc. quarterly report, Q3 FY2026
10-Q
Current report, Q1 FY2026
Lite Strategy, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Lite Strategy, Inc. current report, Q1 FY2026
8-K

2025

Quarterly report, Q2 FY2025
Lite Strategy, Inc. quarterly report, Q2 FY2025
10-Q
Current report, Q4 FY2025
Lite Strategy, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Lite Strategy, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Lite Strategy, Inc. current report, Q4 FY2025
8-K

Lite Strategy, Inc. current report, 29 November 2018

Full document

Business Context and Reporting Period

This Form 8-K filing by MEI Pharma, Inc. (not Lite Strategy, Inc.) reports on events occurring at the Annual Meeting of Stockholders held on November 29, 2018. The filing details the results of five shareholder proposals, including the election of directors, amendments to equity plans and the certificate of incorporation, and the ratification of auditors.

Key Financial Metrics

This filing is a current report regarding corporate governance and shareholder voting results. It does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The filing text does not provide a clear value for any financial performance indicators.

Material Changes and Voting Results

Shareholders representing 54,774,949 shares (out of 71,115,444 outstanding) voted on the following matters:

  • Director Elections: Three directors (Charles V. Baltic, III; Nicholas R. Glover, Ph.D.; Frederick W. Driscoll) were elected to three-year terms expiring in 2022. Each received over 38 million "For" votes.
  • Equity Plan Amendment: The 2008 Stock Omnibus Equity Compensation Plan was amended to increase the number of shares available for award by 8,903,794, bringing the total to 18,496,857 shares. The proposal passed with 37,764,985 "For" votes.
  • Authorized Share Increase: The Certificate of Incorporation was amended to increase authorized common stock from 113,000,000 to 226,000,000 shares. The proposal passed with 51,485,267 "For" votes.
  • Executive Compensation: An advisory vote on executive compensation was approved with 38,053,563 "For" votes.
  • Auditor Ratification: BDO USA, LLP was ratified as the independent auditor for the fiscal year ending June 30, 2019, with 54,472,030 "For" votes.

Guidance, Outlook, and Risks

The filing contains no management commentary regarding future financial guidance, market outlook, or specific risk factors. The primary focus is the administrative approval of corporate governance structures and equity incentives. No unusual items or contingencies were disclosed in this report.

Investor Verification Checklist

  • Verify the full text of the Amended and Restated 2008 Stock Omnibus Equity Compensation Plan (Exhibit 10.1) to understand specific terms of the increased share pool.
  • Confirm the impact of the authorized share increase (from 113M to 226M) on potential future dilution.
  • Review the definitive proxy statement referenced in the filing for detailed biographies of the newly elected directors and specific executive compensation figures.
  • Note that the company is not an emerging growth company and did not elect to use extended transition periods for accounting standards.